$REEAF Cashflow Statement | Understand Stock

$REEAF

$0.01 -$0.01 (60.0%) Close

$REEAF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statement of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization of operating lease right of use asset
Accretion income on short-term investments
Share-based compensation
Financial income with respect to convertible loan, net
Change in fair value of warrants liability
Change in fair value of derivative liability
Amortization of discount of convertible promissory note
Interest expenses
Transaction costs related to warrants
Decrease (increase) in accrued interest on short-term investments
Decrease (increase) in inventory
Decrease (increase) in accounts receivable
Decrease (increase) in other accounts receivable and prepaid expenses
Change in operating lease right-of-use assets and liabilities, net
Increase (decrease) in trade payables
Increase (decrease) in other accounts payable and accrued expenses
Increase (decrease) in deferred tax liability
Decrease in deferred revenue
Impairment of long-lived assets
Loss from property and equipment sales and disposals

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Proceeds from sale of property and equipment
Purchases of short-term investments
Proceeds from short-term investments
Proceeds from bank deposits
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from issuance of Ordinary Shares, net
Proceeds from exercise of options and warrants
Proceeds from issuance of Preferred shares, net
Repayment of short term loan
Proceeds from short term loan
Proceeds from issuance of warrants
Proceeds from bifurcated embedded derivatives
Proceeds from convertible note
Receivables on account of shares
Proceeds from exercise of warrants to preferred shares
Proceeds from SPAC merger and PIPE financing, net of transaction costs
Proceeds from exercise of options
Net cash provided by financing activities

Increase (Decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of period
Non-cash activity:
Deferred transaction costs
Purchase of property and equipment in trade payables and other accounts payable and accrued expenses
Recognition of beneficial conversion feature on convertible loan
Reclassification of warrant liability to equity
Conversion of convertible notes
Derecognition of ROU assets and lease liabilities due to lease reassessment
Share settlement of employee liability
Right-of-use assets obtained in exchange for lease liabilities
Transfer from inventory to property and equipment, net
Prepaid purchases classified as property and equipment

Supplemental disclosure of cash flows information:
Cash received from interest
Cash paid for income taxes
Interest paid
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash
Non-current restricted cash
Total cash, cash equivalents and restricted cash

Comments